TTK Healthcare Limited (BOM:507747)
1,030.80
-18.05 (-1.72%)
At close: Sep 25, 2026
TTK Healthcare Market Cap
TTK Healthcare has a market cap or net worth of 14.57 billion as of September 25, 2026. Its market cap has decreased by -13.12% in one year.
Market Cap
14.57B
Enterprise Value
5.45B
Revenue
8.88B
Ranking
n/a
PE Ratio
19.69
Stock Price
1,030.80
ChartMarket Cap Chart
Since May 28, 2001, TTK Healthcare's market cap has increased from 107.39M to 14.57B, an increase of 13,463.40%. That is a compound annual growth rate of 21.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 14.57B | -0.47% |
| Dec 31, 2025 | 14.63B | -26.89% |
| Dec 31, 2024 | 20.02B | 0.51% |
| Dec 29, 2023 | 19.92B | 40.43% |
| Dec 30, 2022 | 14.18B | 41.69% |
| Dec 31, 2021 | 10.01B | 18.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 24.50B |
| Fredun Pharmaceuticals | 22.50B |
| Venus Remedies | 21.74B |
| Syncom Formulations (India) | 18.88B |
| Amrutanjan Health Care | 14.77B |
| Fermenta Biotech | 13.80B |
| Kopran | 13.10B |
| Lincoln Pharmaceuticals | 11.93B |